N943 400 (Acyclovir 400 mg)
Pill with imprint N943 400 is Blue, Capsule-shape and has been identified as Acyclovir 400 mg. It is supplied by Teva Pharmaceuticals USA.
Acyclovir is used in the treatment of herpes simplex; cold sores; herpes simplex - congenital; herpes simplex encephalitis; herpes simplex, suppression (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for N943 400
Acyclovir
- Imprint:
- N943 400
- Strength:
- 400 mg
- Color:
- Blue
- Size:
- 15.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Purine nucleosides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- Inactive Ingredients:
- silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 54569-4765 | A-S Medication Solutions, LLC (repackager) |
| 00440-1031 | Liberty Pharmaceuticals (repackager) |
More about acyclovir
- Acyclovir Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 121 Reviews – Add your own review/rating
- Drug class: purine nucleosides
Consumer resources
- Acyclovir
- Acyclovir injection
- Acyclovir Buccal Tablets
- Acyclovir Capsules and Tablets
- Acyclovir Suspension
- ... +2 more
Other brands: Zovirax, Sitavig
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
